Nachrichten zur Pfizer Inc. Aktie

Pfizer could use existing US manufacturing to counter potential tariff hit By Reuters

Pfizer could use existing US manufacturing to counter potential tariff hit…

Pfizer could move outside manufacturing to the US, says CEO

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to the U.S., if required, as President…

Pfizer considers moving overseas production to U.S. amid tariff threats By Investing.com

Pfizer considers moving overseas production to U.S. amid tariff threats…

2 Top Stocks Beaten Down Near 52-Week Lows That Look Like Bargains Now

Buying low to sell later when the stocks price is high is a time-honored investing strategy. With the benchmark S&P…

The top 100 biotech investors; FDA vaccine meeting canceled; Can Bill Anderson save Bayer?; and more

Biotech investing saw growth in 2024, with RA Capital leading VCs. FDA cancels flu vaccine meeting, Pfizer hires ex-FDA official…

3 Dividend Stocks That Are No-Brainer Buys Right Now

It can be difficult to decide which dividend stocks to buy. After all, more than 5,700 of them trade on…

Activist Starboard Trailed Peers With Less Than 5% Returns

Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large campaigns…

The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO

Alibaba, Pfizer, MercadoLibre and SIFCO are included in this Analyst Blog.…

Top Research Reports for Alibaba, Pfizer & MercadoLibre

Todays Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Pfizer Inc. (PFE)…

Pfizer: What The Summit Therapeutics Deal Brings

…

Pfizer: No More Growth - Still A Worthy Dividend Buy

…

3 Magnificent Dividend Growth Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade

There are many ways to make money on Wall Street, but some methods are a lot more reliable than others.…

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

Looking for a good area in which to invest? Consider the healthcare sector. People must have healthcare. And with aging…

Pfizer: Pharma-Riese zieht die Reißleine

Keine guten Nachrichten vom US-amerikanischen Pharma-Giganten. Pfizer nimmt seine Gentherapie zur Behandlung der Hämophilie (Bluterkrankheit) vom Markt. Ein weiterer Rückschlag…

Pfizer ends global development of Beqvez gene therapy By Investing.com

Pfizer ends global development of Beqvez gene therapy…

The Smartest Dividend Stocks to Buy With $1,000 Right Now

You have $1,000 (or $200 or $50,000) burning a hole in your pocket and youre itching to invest in some…

Why Pfizers Stock Price Isnt Reflecting Its True Value

…

10 Key Sustainable-Investing Themes and Companies

The charms of IBM, EDP Renovaveis, Pfizer, Baker Hughes, Barclays, and others.…

Love, Money, and Stocks

In this podcast, Motley Fool host Dylan Lewis and analysts Jason Moser and Emily Flippen break down: The Trade Desks 30%…

This Company Just Initiated a Quarterly Dividend: Time to Buy?

Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

Who doesnt want passive income? Even Warren Buffett has extolled it, reportedly saying, "If you dont find a way to…

3 Things You Need to Know If You Buy Pfizer Today

Pfizer (NYSE: PFE) has been around for 175 years, but the companys revenue soared to its highest ever only in…

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Buy low, sell high. That has been a good strategy for investors for a long time. However, finding great stocks…

GSK meningitis jab gets green light from US FDA

GSK PLC has bagged approval for its five-in-one meningitis vaccine from the US Food and Drug Administration, meaning it will…

Pfizer: Danuglipron Could Tip The Scale In A Few Years, But For Now, Sell

…

Commerzbank, Rheinmetall, RWE, Pfizer, AMD, Adobe, UnitedHealth: Die Insider sind am Kaufen

Ziemlich aktiv sind die Insider bei Rheinmetall, Commerzbank, Adobe, Pfizer, AMD, UnitedHealth und RWE. Deren Vorstände kauften überwiegend… Der Beitrag Commerzbank,…

Pfizer wins 2025 Super Bowl with ads likeability, while Hims & Hers spot takes engagement crown: analysts

Hims & Hers’ 2025 Super Bowl commercial generated plenty of c | Hims & Hers “Sick of the System” spot…

Better High-Yield Dividend Stock: Pfizer vs. Merck

Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical…

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

Healthcare stocks have something to offer every investor. If youre looking for high growth, you can try an innovative biotech…

Deutsche Bank Research belässt GSK auf Hold - Ziel 1450 Pence

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für GSK nach Zahlen und einem Treffen mit dem Management…

Fighting Cancer Becomes Top Priority for Pfizer

Pfizer chairman and CEO Albert Bourla sees cancer as Pfizers next big chance to save the world. The complexity of…

Is Now a Good Time to Buy the Dip on Pfizer?

The past three years have been difficult for Pfizer (NYSE: PFE). The pharmaceutical giants financial results worsened substantially as its…

3 Dividend Stocks to Double Up on Right Now

Whats better than a good thing? More of a good thing. Income investors can find plenty of "good things" in the…

Nvidia stock price hinges on massive big tech spending

The four biggest tech companies will spend more on capital projects this year than the combined market value of Pfizer…

Wall Street Week: Concerns About Tariffs and Hope on Cancer

Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even…

Tariffs, Future of Cancer and Alzheimers, Global Debt Cycles | Wall Street Week

This week, Former US Treasury Secretary Lawrence H. Summers and Council on Foreign Relations Director of Studies Shannon ONeil tell…

Personalized Cell Therapy Market: Growing at a CAGR of 25% From 2024-2032 | Pfizer, CARsgen Therapeutics, Mesoblast Ltd

Bristol Myers Squibbs FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, tackling unmet cancer needs.…

Pfizer: Jetzt purzeln die Kursziele

Der amerikanische Pharma-Riese hat ordentliche Zahlen zum vierten Quartal vorgelegt und die im Dezember formulierte Prognose bestätigt. Für einen nachhaltigen…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…

Pfizer übertrifft Umsatzerwartung - Aktie gefragt

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen…

Pfizer peilt für 2025 Umsatz auf Vorjahreshöhe an - Gewinnsteigerung möglich

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer blickt verhalten auf das kommende Jahr. 2025 werde…

Prozess um von der Leyens SMS mit Pfizer geht in heiße Phase

LUXEMBURG (dpa-AFX) - Der Prozess um SMS zwischen EU-Kommissionspräsidentin Ursula von der Leyen und dem Chef…

Pfizer erhöht erneut Prognose - Aktie vorbörslich im Plus

NEW YORK (dpa-AFX) - Beim US-Pharmakonzern Pfizer geht es weiter aufwärts. Nach einem abermals unerwartet…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem…

Pfizer will bis Ende 2027 rund 1,5 Milliarden US-Dollar einsparen

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer will bis Ende 2027 rund 1,5 Milliarden US-Dollar…

WDH/ANALYSE-FLASH: Jefferies belässt Pfizer auf 'Buy' - Ziel 32 Dollar

(Wiederholung vom Vorabend) NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…

ANALYSE-FLASH: Jefferies senkt Ziel für Pfizer auf 32 Dollar - 'Buy'

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für Pfizer nach Zielvorgaben…

Pfizer stoppt eine Studie mit seiner Abnehm-Tablette wegen Nebenwirkungen

NEW YORK (dpa-AFX) - Der Pharmakonzern Pfizer stoppt die Entwicklung seines Abnehm-Medikaments Danuglipron in einem…

ANALYSE-FLASH: Jefferies hebt Pfizer auf 'Buy' - Ziel hoch auf 39 Dollar

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat Pfizer von "Hold" auf "Buy" hochgestuft…